aliskiren / Hydrochlorothiazide

Known as: ALISKIREN/HYDROCHLOROTHIAZIDE, aliskiren and hydrochlorothiazide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2014
0120082014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND Aliskiren, a direct renin inhibitor, is effective for reducing blood pressure (BP) in patients with hypertension when… (More)
Is this relevant?
2012
2012
In a prespecified subgroup analysis of a 12-week multinational, randomized, double-blind, parallel-group trial, self-identified… (More)
  • table I
  • table II
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
2011
2011
Patients with stage 2 hypertension and diabetes are at high cardiovascular risk and require large blood pressure (BP) reductions… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
BACKGROUND Single-pill combinations of aliskiren/hydrochlorothiazide have recently been approved by the European Medicines Agency… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
Patients with stage 2 hypertension (systolic blood pressure [SBP] ≥160mm Hg and/or diastolic blood pressure [DBP] ≥100mm Hg) are… (More)
Is this relevant?
2009
2009
OBJECTIVE Thiazide diuretics such as hydrochlorothiazide (HCT) are a widely used first-line treatment for hypertension, but most… (More)
Is this relevant?
2009
2009
Aliskiren/hydrochlorothiazide is a single-pill combination of the first in the new class of non-peptide direct renin inhibitors… (More)
Is this relevant?
Review
2008
Review
2008
Hypertension is a major risk factor for the development of cardiovascular and renal disease. The incidence of hypertension is… (More)
  • figure 1
  • table 1
Is this relevant?